SECOND AMENDMENT TO THE REVENUE AND NEGOTIATION RIGHTS AGREEMENTRevenue and Negotiation Rights Agreement • October 31st, 2014 • EPIRUS Biopharmaceuticals, Inc. • Pharmaceutical preparations • New York
EPIRUS SWITZERLAND GMBH, a corporation organized under the laws of Switzerland, with registered office at General-Guisan-Strasse 6, 6303 Zug Switzerland (hereinafter referred to as “EPIRUS”), and as a successor to FOURTEEN22, INC. (“FOURTEEN22”), represented herein by its undersigned legal representative(s), and
REVENUE AND NEGOTIATION RIGHTS AGREEMENTRevenue and Negotiation Rights Agreement • August 11th, 2014 • EPIRUS Biopharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Revenue and Negotiation Rights Agreement (the “Agreement”), dated as of December 31, 2010 (the “Effective Date”), is entered into by and between moksha8 Pharmaceuticals, Inc. (“Moksha8”), a Delaware corporation with a mailing address of 1550 Liberty Ridge Drive, Suite 300, Wayne, PA 19087, and fourteen22, Inc. (“Fourteen22”), a Cayman Islands company with registered office at c/o Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands. Moksha8 and Fourteen22 shall be referred to herein individually as a “Party” and collectively as the “Parties.”
FIRST AMENDMENT TO THE REVENUE AND NEGOTIATION RIGHTS AGREEMENTRevenue and Negotiation Rights Agreement • September 29th, 2014 • EPIRUS Biopharmaceuticals, Inc. • Pharmaceutical preparations • New York
EPIRUS SWITZERLAND GMBH, a corporation organized under the laws of Switzerland, with registered office at General-Guisan-Strasse 6, 6303 Zug Switzerland (hereinafter referred to as “EPIRUS”), and as a successor to FOURTEEN22, INC. (“FOURTEEN22”), represented herein by its undersigned legal representative(s), and
